Highest-materiality recent filing
Ventas appoints Laurida Sayed as SVP, Chief Accounting Officer and Controller
Sayed, 44, joins from Cushman & Wakefield, where she was CAO since May 2024; effective Oct 5, 2026.
Ventas Q2 Normalized FFO $0.97 (+9% YoY); raises full-year guidance on $3.4B YTD investments
Attributable net income $0.14/share; Normalized FFO $0.97/share, up 9% YoY.
Ventas EVP, General Counsel Carey S. Roberts resigns to join Blackstone; interim replacement named
Carey S. Roberts, EVP General Counsel & Secretary, resigns effective June 26, 2026 to join Blackstone.
Ventas ups ATM equity capacity to $3.0B; all 12 directors elected at annual meeting
Amendment No. 3 to ATM Sales Agreement raises aggregate gross sales price to $3.0B, excluding prior sales.
Ventas Q1 Normalized FFO $0.94 (+9% YoY); raises FY investment outlook to $3B
Attributable Net Income $0.11 per share; Normalized FFO $0.94 per share (+9% YoY).
Ventas CAO Gregory R. Liebbe resigns; CFO Probst assumes interim CAO role
Gregory R. Liebbe, SVP, Chief Accounting Officer & Controller, resigns effective Feb 27, 2026.
Ventas ups ATM equity program to $2.5B, adds M&T Securities as agent
ATM facility aggregate gross sales price increased to $2.5 billion; excludes shares already sold.
Ventas Q4 Normalized FFO $0.89, up 10% YoY; increases quarterly dividend
Q4 Normalized FFO per share $0.89 vs $0.81; FY 2025 Normalized FFO $3.48 vs $3.19.
Ventas ups term loan to $700M, adds $550M delayed draw; repays 2023 facility
Term loan facility increased from $500M to $700M; new delayed draw term loan facility of $550M established.
Ventas Realty issues $500M of 5.000% Senior Notes due 2036
Ventas Realty issued $500M aggregate principal of 5.000% Senior Notes due 2036.
Ventas EVP Peter Bulgarelli to retire May 1, 2026; search for successor underway
Peter J. Bulgarelli, EVP of Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, plans to retire effective May 1, 2026.
Ventas reports Q3 2025 Normalized FFO $0.88 (+10% YoY); raises full-year guidance
Net Income Attributable to Common Stockholders per share $0.14 in Q3 2025.
Ventas Q2 Normalized FFO $0.87 (+9% YoY); SHOP Same-Store NOI +13%; guidance raised
Attributable Net Income per share $0.15; Normalized FFO per share $0.87, +9% YoY.
Ventas ups ATM equity capacity to $2.25B under amended sales agreement
Amendment No. 1 increases aggregate gross sales price to $2.25B, excluding prior sales under the agreement.
Ventas subsidiary issues $500M 5.100% Senior Notes due 2032
Ventas Realty issued $500M in 5.100% Senior Notes due 2032 in a public offering.
Ventas shareholders approve doubling authorized shares and officer exculpation at annual meeting
Authorized common shares increased from 600M to 1.2B via Charter Amendment; filed May 14, 2025.
Ventas Q1 normalized FFO $0.84 (+8% YoY); credit facility expanded to $3.5B
Q1 normalized FFO per share $0.84 (+8% YoY); GAAP EPS $0.10.
Ventas reports 2024 FFO/share $3.19 (+7% YoY); increases dividend, provides 2025 guidance
Attributable Net Income per share $0.19; Normalized FFO per share $3.19, up ~7% YoY.
Ventas prices 10.6M-share forward equity offering at $63.71/share
Underwriting agreement for 10.6M shares of common stock plus 1.59M share option.
Ventas Q3 Normalized FFO $0.80 (+7% YoY), SHOP NOI +15.3%, raises guidance
Attributable net income $0.05/sh; Normalized FFO $0.80/sh (+7% YoY).
Ventas establishes new $2B at-the-market stock offering program, replacing prior $1B program
New ATM agreement allows issuance of up to $2B in common stock through multiple agents and forward purchasers.
Ventas subsidiary issues $550M of 5.000% Senior Notes due 2035
Ventas Realty, LP issued $550M aggregate principal of 5.000% Senior Notes due 2035.
Ventas Q2 normalized FFO $0.80 (+7% YoY); SHOP same-store NOI +15.2%
Normalized FFO per share $0.80, up 7% YoY.
All 12 director nominees elected; Debra Cafaro received 290.1M votes for, 44.0M against, 17.4M abstain.
Ventas Realty issues $500M of 5.625% Senior Notes due 2034
$500M aggregate principal of 5.625% Senior Notes due 2034 issued by Ventas Realty, a wholly owned subsidiary of Ventas, Inc.
Ventas Q1: Net loss $(0.04)/shr; Normalized FFO $0.78 (+5% YoY); guides up
Normalized FFO per share $0.78, up >5% YoY; net loss $(0.04) per share.
Ventas enters into $2.75B amended revolver, maturing April 2028
New $2.75B unsecured revolving credit facility replaces existing credit agreement.
Ventas director James D. Shelton to retire, Roxanne Martino to become Lead Independent Director
James D. Shelton, Lead Independent Director and 16-year board member, will not stand for re-election at 2024 annual meeting.
Ventas and Land & Buildings reach cooperation agreement; two new directors
Ventas appoints Theodore Bigman (former Morgan Stanley executive) and Joe V. Rodriguez (former Invesco CIO) to the Board.
Ventas Canada prices Cdn$650M 5.10% Senior Notes due 2029
Cdn$650 million principal, 5.10% coupon, due March 5, 2029; expected close March 5, 2024.
Ventas increases at-the-market equity offering capacity to $1.0 billion
Filed new S-3 registration statement replacing expiring one; amended existing ATM Sales Agreement.
Ventas Q4 2023 Nareit FFO $0.79 (+21.5%); FY 2023 Nareit FFO $3.26 (+15.6%); provides 2024 outlook
Q4 2023 Nareit FFO $0.79 per share (+21.5% YoY); Normalized FFO $0.76 (+4.1%).
Ventas Q3: Normalized FFO $0.75 (+6% YoY); SHOP Same-Store NOI +18%; raises FY guidance midpoint
Net loss of ($0.18) per share, including $0.18/share of non-cash impairments on assets held for sale.
Ventas Realty enters $200M unsecured term loan, maturing Feb 2027
Ventas Realty, L.P. signed a $200 million unsecured term loan facility on Sept 6, 2023, with Bank of America as administrative agent.
Ventas Q2 Normalized FFO $0.75, same-store cash NOI +7%, SHOP +14% YoY
Net income of $0.26 per share; Normalized FFO of $0.75 per share.
Ventas issues $862.5M 3.75% exchangeable notes due 2026, net proceeds ~$844M
$862.5M aggregate principal of 3.75% exchangeable notes due June 1, 2026.
Ventas Realty prices $750M 3.75% exchangeable notes due 2026, upsized from $500M
Principal $750M at 3.75% interest, mature June 1, 2026; exchangeable at $54.81/share (22.5% premium to $44.74 close).
Ventas shareholders elect all 11 director nominees at annual meeting
All 11 director nominees elected with majority support; CEO Debra Cafaro received 302.6M votes for, 27.0M against.
Ventas Q1 Net Income $0.04/sh, Normalized FFO $0.74; same-store SHOP NOI +17.4% YoY
Net Income per share $0.04; Normalized FFO per share $0.74.
Priced Cdn$600M of 5.398% Senior Notes, Series I due 2028; expected close April 21, 2023.
Ventas Q4 net loss $0.11/share, normalized FFO $0.73; same-store NOI +8.5% YoY
Net loss attributable to common stockholders per share ($0.11); Normalized FFO per share $0.73.
J. Justin Hutchens, EVP Senior Housing, appointed as Chief Investment Officer effective Jan 23, 2023, adding responsibility for capital allocation.
Ventas Q3 2022: Net income break-even, Normalized FFO $0.76, same-store NOI +4.8%
Net income attributable to common stockholders per share $0.00; Normalized FFO per share $0.76, including ~$20M ( $0.05/sh) HHS grants.
Ventas appoints Realty Income CEO Sumit Roy to Board; director Robert Reed to retire in 2023
Sumit Roy (President & CEO of Realty Income) appointed as independent director, effective Oct 1, 2022; will serve on Investment Committee.
Ventas Q2 2022 normalized FFO $0.72; same-store NOI up 3.5% above guidance
Attributable net loss per share ($0.11); normalized FFO per share $0.72.
Ventas enters $500M term loan facility, repays ~$200M existing debt
New $500M unsecured term loan facility replaces $300M (2023) and $600M (2024) facilities.
Ventas amends bylaws to eliminate supermajority voting, updates proxy rules
Eliminates supermajority stockholder vote for bylaw amendments; replaced with majority of outstanding shares.
Ventas 8-K reports Q1 2022 earnings press release; figures not included in filing text.
Filing states press release issued May 5, 2022 for quarter and year ended March 31, 2022.
Ventas shareholders elect 11 directors; approve Say-on-Pay, 2022 plan, and KPMG ratification
All 11 director nominees elected; highest votes withheld was James D. Shelton with 59.2M withheld.
Ventas appoints Embler to board, Gellert retires; Land & Buildings launches proxy fight
Jay M. Gellert will not stand for re-election at 2022 annual meeting after serving since 2001.
approved the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer and Controller of the Company, effective on or around October 5, 2026
As of the Effective Date, Robert F. Probst, the Company’s Executive Vice President and Chief Financial Officer, will no longer perform the responsibilities of Chief Accounting Officer on an interim basis.
On June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc. (“Ventas” or the “Company”) notified Ventas of her intention to resign from the Company effective June 26, 2026 (the “Effective Date”).
On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc.
On March 4, 2024, James D. (“Denny”) Shelton advised the Board of Directors (the “Board”) of Ventas, Inc. (we,” “us,” “our,” “Company” and other similar terms) that he will not stand for re-election as a director of the Company at the 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
The Board has unanimously appointed Roxanne Martino, a director since 2016 and former CEO of Aurora Investment Management, as Lead Independent Director, effective following the 2024 Annual Meeting.
On March 4, 2024, Theodore R. Bigman and Joe V. Rodriguez, Jr. were appointed to the Board effective immediately.
On March 4, 2024, Theodore R. Bigman and Joe V. Rodriguez, Jr. were appointed to the Board effective immediately.
Ventas, Inc. ( “we,” “us,” “our,” the “Company” and other similar terms ) has announced that J. Justin Hutchens, current Executive Vice President, Senior Housing, has been appointed to the additional role of Chief Investment Officer, effective as of January 23, 2023.
John D. Cobb stepped down as Executive Vice President and Chief Investment Officer, also effective as of January 23, 2023.
On September 12, 2022, Robert D. Reed, a director of the Company, advised the Board that he will not stand for re-election as a director of the Company at the 2023 annual meeting of stockholders.
On September 12, 2022, Sumit Roy, President & Chief Executive Officer at Realty Income Corporation, was appointed as an independent director to the Board of Directors (the “Board”) of Ventas, Inc.
Max materiality 0.85 · Median 0.57 · Most common event earnings